 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
Anergix, LLC was founded in October 2007 to commercialize the antigen specific approach to inducing anergy or tolerance to targeted peptides in MS and other autoimmune diseases. The company will leverage and expand upon the early research work of Dr. Leslie Weiner and Dr. Minnie McMillan both from the USC Keck School of Health Sciences.
|
|
